The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose-escalation study of GCC19CART: A novel CAR T-cell therapy for metastatic colorectal cancer in the United States.
 
Bridget Keenan
Employment - Astellas Pharma (I)
Consulting or Advisory Role - Regeneron
Research Funding - Antengene (Inst); Apexigen (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Innovative Cellular Therapeutics Co (Inst); Partner Therapeutics (Inst); Regeneron (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Christopher Lieu
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Genentech (Inst)
 
Marwan Fakih
Honoraria - Amgen
Consulting or Advisory Role - Abbvie; Adagene; Bayer; BMS; Delcath Systems; Eisai; Entos; Janssen Research & Development; Merck; Microbial Machines; Mirati Therapeutics; Nouscom; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Tempus; Totus Medicines
Research Funding - Agenus (Inst); Roche/Genentech (Inst); Verastem (Inst)
 
Alan Venook
Consulting or Advisory Role - Abbvie; Amgen; Exact Sciences; Exelixis; INTERA; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
 
Dongqi Chen
No Relationships to Disclose
 
Eric Rowinsky
No Relationships to Disclose
 
Victor Lu
No Relationships to Disclose
 
Lei Xiao
No Relationships to Disclose
 
Benjamin Schlechter
Consulting or Advisory Role - Agenus; Janssen; Quercegen Pharmaceuticals